Pathway-based Genome-wide Association Studies Reveal the Association between Growth Factor Activity and Inflammatory Bowel Disease

Inflammatory Bowel Diseases

Volumn 22, Issue 7, 2016, Pages 1540-1551

  Li, Jin ^a   Wei, Zhi ^b   Chang, Xiao ^a   Cardinale, Christopher J ^a   Kim, Cecilia E ^a   Baldassano, Robert N ^a,c   Hakonarson, Hakon ^a,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

growth factor activity; inflammatory bowel disease; pathway analysis

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; PROTEIN KINASE C BETA; STAT PROTEIN; CYTOKINE; CYTOKINE RECEPTOR; SIGNAL PEPTIDE;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; EPIGENETICS; EUROPEAN; GENE ACTIVITY; GENE EXPRESSION; GENETIC ASSOCIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE TRAIT LOCUS; REPLICATION STUDY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; AUTOIMMUNE DISEASE; CAUCASIAN; GENE ONTOLOGY; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; META ANALYSIS; METABOLISM; PROCEDURES; PROTEIN ANALYSIS; PROTEIN DOMAIN;

AUTOIMMUNE DISEASES; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; DATABASES, GENETIC; EPIDERMAL GROWTH FACTOR; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE ONTOLOGY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; QUANTITATIVE TRAIT LOCI; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 84976310117     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000785     Document Type: Article

References (61)

1. Rubin GP, Hungin AP, Kelly PJ, et al. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther. 2000;14:1553-1559
2. Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146:35-40
3. Van Limbergen J, Wilson DC, Satsangi J. The genetics of Crohn's disease. Annu Rev Genomics Hum Genet. 2009;10:89-116
4. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008;8:458-466
5. Lees CW, Barrett JC, Parkes M, et al. New IBD genetics: common pathways with other diseases. Gut. 2011;60:1739-1753
6. Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to. Nat Genet. 2011;43:246-252
7. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118-1125
8. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124
9. Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979-986
10. Wang K, Li M, Hakonarson H. Analysing biological pathways in genomewide association studies. Nat Rev Genet. 2010;11:843-854
11. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545-15550
12. Wang K, Zhang H, Kugathasan S, et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn disease. Am J Hum Genet. 2009;84:399-405
13. Holmans P, Green EK, Pahwa JS, et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet. 2009;85:13-24
14. Ballard D, Abraham C, Cho J, et al. Pathway analysis comparison using Crohn's disease genome wide association studies. BMC Med Genomics. 2010;3:25
15. Carbonetto P, Stephens M. Integrated enrichment analysis of variants and pathways in genome-wide association studies indicates Central role for IL-2 signaling genes in type 1 diabetes, and cytokine signaling genes in Crohn's disease. PLoS Genet. 2013;9:e1003770
16. Torkamani A, Topol EJ, Schork NJ. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics. 2008;92: 265-272
17. Peng G, Luo L, Siu H, et al. Gene and pathway-based second-wave analysis of genome-wide association studies. Eur J Hum Genet. 2010; 18:111-117
18. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575
19. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904-909
20. Liu JZ, McRae AF, Nyholt DR, et al. A versatile gene-based test for genome-wide association studies. Am J Hum Genet. 2010;87:139-145
21. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267-273
22. Razick S, Magklaras G, Donaldson IM. iRefIndex: a consolidated protein interaction database with provenance. BMC Bioinformatics. 2008; 9:405
23. Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25:1091-1093
24. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498-2504
25. Lu Y, Vitart V, Burdon KP, et al. Genome-wide association analyses identify multiple loci associated with Central corneal thickness and keratoconus. Nat Genet. 2013;45:155-163
26. Scott RA, Lagou V, Welch RP, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012;44:991-1005
27. Springelkamp H, Hohn R, Mishra A, et al. Meta-analysis of genome-wide association studies identifies novel loci that influence cupping and the glaucomatous process. Nat Commun. 2014;5:4883
28. Cartlidge SA, Elder JB. Transforming growth factor alpha and epidermal growth factor levels in normal human gastrointestinal mucosa. Br J Cancer. 1989;60:657-660
29. Messa C, Russo F, Caruso MG, et al. EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma. Acta Oncol. 1998;37:285-289
30. Lu N, Wang L, Cao H, et al. Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis. J Immunol. 2014;192:1013-1023
31. Roadmap Epigenomics C, Kundaje A, Meuleman W, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518:317-330
32. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:D930-D934
33. Consortium GT. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648-660
34. Egger B, Buchler MW, Lakshmanan J, et al. Mice harboring a defective epidermal growth factor receptor (waved-2) have an increased susceptibility to acute dextran sulfate-induced colitis. Scand J Gastroenterol. 2000;35:1181-1187
35. Procaccino F, Reinshagen M, Hoffmann P, et al. Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology. 1994;107:12-17
36. Feng Y, Teitelbaum DH. Epidermal growth factor/TNF-alpha transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition. Am J Physiol Gastrointest Liver Physiol. 2012;302: G236-G249
37. Pallone F, Fais S, Capobianchi MR. HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clin Exp Immunol. 1988;74:75-79
38. Jahanshahi G, Motavasel V, Rezaie A, et al. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig Dis Sci. 2004;49: 1752-1757
39. Oikonomou KA, Kapsoritakis AN, Kapsoritaki AI, et al. Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage? Growth Factors. 2010;28: 461-466
40. Banan A, Zhang Y, Losurdo J, et al. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut. 2000;46:830-837
41. Banan A, Fields JZ, Zhang LJ, et al. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappa-Balpha degradation: a fundamental mechanism for epidermal growth factor Protection of the microtubule cytoskeleton and intestinal barrier integrity. J Pharmacol Exp Ther. 2003;307:53-66
42. Dube PE, Yan F, Punit S, et al. Epidermal growth factor receptor inhibits colitis-associated cancer in mice. J Clin Invest. 2012;122:2780-2792
43. Feng Y, McDunn JE, Teitelbaum DH. Decreased phospho-Akt signaling in a mouse model of total parenteral nutrition: a potential mechanism for the development of intestinal mucosal atrophy. Am J Physiol Gastrointest Liver Physiol. 2010;298:G833-G841
44. Wang JY, Zhang LH, Song WL. Epidermal growth factor regulates intestinal glutamine uptake during total parenteral nutrition. Clin Nutr. 1996; 15:21-23
45. Chiu T, Santiskulvong C, Rozengurt E. EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway. Am J Physiol Gastrointest Liver Physiol. 2005;288:G182-G194
46. Nose K, Yang H, Sun X, et al. Glutamine prevents total parenteral nutrition-associated changes to intraepithelial lymphocyte phenotype and function: a potential mechanism for the preservation of epithelial barrier function. J Interferon Cytokine Res. 2010;30:67-80
47. Frey MR, Brent Polk D. ErbB receptors and their growth factor ligands in pediatric intestinal inflammation. Pediatr Res. 2014;75:127-132
48. Krishnan K, Arnone B, Buchman A. Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing. Inflamm Bowel Dis. 2011;17:410-422
49. Gyires K, Toth VE, Zadori ZS. Gut inflammation: current update on pathophysiology, molecular mechanism and pharmacological treatment modalities. Curr Pharm Des. 2014;20:1063-1081
50. Sinha A, Nightingale J, West KP, et al. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med. 2003;349:350-357
51. Barahona-Garrido J, Hernandez-Calleros J, Garcia-Juarez I, et al. Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility. Saudi J Gastroenterol. 2009;15:208-212
52. Klinger B, Sieber A, Fritsche-Guenther R, et al. Network quantification of EGFR signaling unveils potential for targeted combination therapy. Mol Syst Biol. 2013;9:673
53. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674
54. Spano JP, Fagard R, Soria JC, et al. Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives. Ann Oncol. 2005;16:189-194
55. Markman B, Javier Ramos F, Capdevila J, et al. EGFR and KRAS in colorectal cancer. Adv Clin Chem. 2010;51:71-119
56. Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 2009;29:2727-2737
57. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther. 2006;23:1097-1104
58. von Roon AC, Reese G, Teare J, et al. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum. 2007;50:839-855
59. Alexander RJ, Panja A, Kaplan-Liss E, et al. Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease. Dig Dis Sci. 1995;40:485-494
60. Fan S, Pan Z, Geng Q, et al. Layered signaling regulatory networks analysis of gene expression involved in malignant tumorigenesis of non-resolving ulcerative colitis via integration of cross-study microarray profiles. PLoS One. 2013;8:e67142
61. Huynh E, Li J. EGF and EGFR: Promising targets for modulating inflammation and mucosal healing therapy in IBD. Inflamm Cell Signal. 2015;2:e840